Knights of Columbus Asset Advisors LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Knights of Columbus Asset Advisors LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,115
-55.5%
16,0920.0%0.00%
-57.1%
Q2 2023$76,598
-53.5%
16,092
-44.3%
0.01%
-56.2%
Q1 2023$164,587
-43.5%
28,8750.0%0.02%
-46.7%
Q4 2022$291,349
-55.5%
28,875
-1.0%
0.03%
-55.2%
Q3 2022$654,000
+3.0%
29,178
+13.8%
0.07%
+6.3%
Q2 2022$635,000
-35.9%
25,645
+0.4%
0.06%
-25.0%
Q1 2022$990,000
-33.0%
25,545
+1.1%
0.08%
-29.4%
Q4 2021$1,478,000
+0.7%
25,257
+2.0%
0.12%
-9.2%
Q3 2021$1,467,000
-31.7%
24,758
+0.1%
0.13%
-33.8%
Q2 2021$2,147,000
+19.0%
24,738
+13.1%
0.20%
+11.9%
Q1 2021$1,804,000
-10.5%
21,878
-1.3%
0.18%
-17.3%
Q4 2020$2,016,000
+39.5%
22,166
-38.7%
0.21%
+19.6%
Q3 2020$1,445,000
+1.7%
36,153
-12.7%
0.18%
+2.9%
Q2 2020$1,421,000
+61.7%
41,407
+4.6%
0.17%
+56.8%
Q1 2020$879,000
-31.2%
39,599
-39.3%
0.11%
-1.8%
Q4 2019$1,278,00065,2860.11%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders